Extracellular Vesicles of Alzheimer's Disease Patients as a Biomarker for Disease Progression
- 1 October 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Molecular Neurobiology
- Vol. 57 (10), 4156-4169
- https://doi.org/10.1007/s12035-020-02013-1
Abstract
Alzheimer's disease (AD) is a progressive neurodegenerative brain pathology and the most common form of dementia. Evidence suggests that extracellular vesicles (EVs) containing cytokines and microRNA are involved in inflammation regulation. The current study aimed to explore a potential impact of AD patients' EVs on disease progression. Blood samples were collected after obtaining signed informed consent (No. 0462-14-RMB) from 42 AD patients at three stages of disease severity and from 19 healthy controls (HC). EV size and concentration were studied by nanotracking analysis. EV membrane antigens were defined by flow cytometry and Western blot; EV protein contents were screened by protein array; the miRNA content was screened by nanostring technology and validated by RT-PCR. HC and AD patients' EVs consisted of a mixture of small (< 100 nm) and larger vesicles. The myelin oligodendrocyte glycoprotein (MOG) expression on EVs correlated with disease severity. EVs of patients with moderate and severe AD had significantly higher levels of MOG, compared with mild AD patients. Levels of EVs expressing the axonal glycoprotein CD171 were significantly higher in severe AD patients than in HC. Increase in endothelial EVs was observed in AD patients. An above twofold increase was found in the content of inflammatory cytokines and > 50% decrease in growth factors in AD patients' EVs compared with HC-EVs. Levels of let-7g-5p, miR126-3p, miR142-3p, miR-146a-5p, and mir223-3p correlated with disease severity. Neural damage, specific miRNA downregulation, and inflammatory cytokine upregulation, found in patients' EVs, might be used as a biomarker reflecting AD severity.This publication has 77 references indexed in Scilit:
- Circulating miRNA Biomarkers for Alzheimer's DiseasePLOS ONE, 2013
- Extracellular vesicle sizing and enumeration by nanoparticle tracking analysisJournal of Extracellular Vesicles, 2013
- Extracellular vesicles as mediators of neuron-glia communicationFrontiers in Cellular Neuroscience, 2013
- The Exosome Secretory Pathway Transports Amyloid Precursor Protein Carboxyl-terminal Fragments from the Cell into the Brain Extracellular SpaceOnline Journal of Public Health Informatics, 2012
- DIANA miRPath v.2.0: investigating the combinatorial effect of microRNAs in pathwaysNucleic Acids Research, 2012
- Exosome-associated Tau Is Secreted in Tauopathy Models and Is Selectively Phosphorylated in Cerebrospinal Fluid in Early Alzheimer Disease*Journal of Biological Chemistry, 2012
- Microvesicles: Novel Biomarkers for Neurological DisordersFrontiers in Physiology, 2012
- Elevated Plasma Endothelial Microparticles in Alzheimer’s DiseaseDementia and Geriatric Cognitive Disorders, 2012
- The role of inflammatory cytokines in endothelial dysfunctionBasic Research in Cardiology, 2008
- Alzheimer's disease beta-amyloid peptides are released in association with exosomesProceedings of the National Academy of Sciences of the United States of America, 2006